Although FOXL2 mutation is associated with early relapse and worse outcome [19], other alternative immune stains, such as CD56, SMAD3, Inhibin A and Calretinin, can be utilized as independent predictors of GCT recurrence [20]. The gene discussed is FOXL2; the disease is granular cell tumor.